Trichem Pharmascience

Mumbai, India Founded: 1998 • Age: 28 yrs Acquired By IMCD
Specialty chemicals and intermediates are supplied to pharmaceutical manufacturers.

About Trichem Pharmascience

Trichem Pharmascience is a Healthcare company based in Mumbai (India) founded in 1998, and was acquired by IMCD in June 2025. Specialty chemicals and intermediates are supplied to pharmaceutical manufacturers. Trichem Pharmascience offers products and services including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity in India is Trichem Pharmascience LLP (ABC-1474). Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.

Company details

Trichem Pharmascience LLP was founded in 1998 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where specialty chemicals and intermediates are manufactured for various industries. Expertise is held in facility maintenance products and coatings, with applications in high-heat and high-pressure environments. A presence is maintained across India, ensuring products and services meet industry standards.

Key Metrics

Products & Services of Trichem Pharmascience

Trichem Pharmascience offers a comprehensive portfolio of products and services, including Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.

Clindamycin HCl
API

Antibiotic API used in pharmaceutical formulations.

Paclitaxel IP
API

Chemotherapy API for cancer treatment applications.

Gemcitabine HCl
API

Anticancer API for medical and therapeutic use.

Doxorubicin HCl
API

Antibiotic and chemotherapy API for oncology.

Investors in Trichem Pharmascience

Trichem Pharmascience has secured backing from 1 investor. Prominent investors backing the company include IMCD.

All
InvestorDescriptionFounded YearDomainLocation
Speciality chemicals and food ingredients are distributed by IMCD.
1995imcdgroup.comRotterdam, Netherlands
Premium access

Investor details for Trichem Pharmascience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Pharmadose Generics Llp (Trichem Pharmascience)

Pharmadose Generics Llp is the primary company behind Trichem Pharmascience. The boards of the 4 registered companies of Trichem Pharmascience currently have 7 directors; the longest-serving is Manojkumar Sampatmal Kucheria, appointed in 2007. 14 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Manojkumar Sampatmal Kucheria
DIN 01423828
Director12 Apr 200719 yrs 7 moTrichem Intermediates Private Limited
Abhishek Manoj Kucheria
DIN 07551019
Director05 Nov 20188 yrsTrichem Intermediates Private Limited
Heena Chetan Jain
DIN 09689277
Designated Partner20 Aug 20224 yrs 3 moPharmadose Generics Llp
Chetan Ramesh Jain
DIN 00217531
Designated Partner20 Aug 20224 yrs 3 moPharmadose Generics Llp
Ramanuj Chandrashekhar Kankani
DIN 08274950
Director26 Jun 20251 yr 4 moTrichem Healthcare Private Limited, Trichem Lifesciences Limited
Narendra Sujit Varde
DIN 09026419
Director26 Jun 20251 yr 4 moTrichem Healthcare Private Limited, Trichem Lifesciences Limited
Palak Vij
DIN 11201756
Additional Director18 Jul 20251 yr 4 moTrichem Lifesciences Limited

Timeline of Trichem Pharmascience

2 dated milestones of Trichem Pharmascience across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded Trichem Pharmascience is founded.
  2. Exit Acquired by IMCD.

Competitors of Trichem Pharmascience

Trichem Pharmascience has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viyash.com2019Hyderabad, India$120.02M277
APIs and intermediates are manufactured by Viyash as a CDMO.
inventys.in2005Mumbai, India$64.34M219
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
bluejethealthcare.com1969Mumbai, India476
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
Premium access

Detailed competitors of Trichem Pharmascience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Trichem Pharmascience

The website of Trichem Pharmascience (tricheminc.net) receives about 2.1K visits a month.

  • Monthly visits
    2.1K

    ▲ 43.4% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Trichem Pharmascience (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Trichem Pharmascience

Trichem Pharmascience was founded in 1998.

Trichem Pharmascience is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Trichem Pharmascience LLP was founded in 1998 and is headquartered in Mumbai, India. Operations focus on the pharmaceutical sector, where specialty chemicals and intermediates are manufactured for various industries. Expertise is held in facility maintenance products and coatings, with applications in high-heat and high-pressure environments. A presence is maintained across India, ensuring products and services meet industry standards.

Trichem Pharmascience's top competitors include Inventys, Viyash and Blue Jet Healthcare.

Trichem Pharmascience offers Clindamycin HCl, Paclitaxel IP, Gemcitabine HCl, and Doxorubicin HCl.

Trichem Pharmascience has 1 investor. Key investors include IMCD.

Trichem Pharmascience is associated with 4 legal entities: Pharmadose Generics Llp, Trichem Intermediates Private Limited, Trichem Healthcare Private Limited and others.

Yes. Trichem Pharmascience was acquired by IMCD in June 2025.

The legal entities of Trichem Pharmascience currently have 7 directors, including Heena Chetan Jain, Chetan Ramesh Jain, Manojkumar Sampatmal Kucheria and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available